Pancreatic Cancer Research

ResearcherShandong UniversityNo recent work listed

Jun Niu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-4351-4645; OpenAlex author ID A5101954800. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 3

  1. TIPE3 is a candidate prognostic biomarker promoting tumor progression via elevating RAC1 in pancreatic cancer. Co-author DOI 10.1186/s12943-022-01626-5↗
  2. Integrin β6 acts as an unfavorable prognostic indicator and promotes cellular malignant behaviors via ERK-ETS1 pathway in pancreatic ductal adenocarcinoma (PDA… Co-author DOI 10.1007/s13277-015-4353-7↗
  3. mRNA expression of somatostatin receptor subtypes SSTR-2, SSTR-3, and SSTR-5 and its significance in pancreatic cancer. Last author DOI 10.1186/s12957-015-0467-z↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zequn Li · 1 shared paper, 2022 · strength 0.17
  2. Yanbing Zhou · 1 shared paper, 2022 · strength 0.17
  3. Yuqi Sun · 1 shared paper, 2022 · strength 0.17
  4. Huijie Gao · 1 shared paper, 2016 · strength 0.06
  5. Zequn Li · 1 shared paper, 2016 · strength 0.06
  6. Weibo Niu · 1 shared paper, 2016 · strength 0.06
  7. Muhammad Shahbaz · 1 shared paper, 2015 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.